Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind study of norfloxacin vs placebo on survival in patients with decompensated cirrhosis (Child-Pugh C)
2009-012919-17Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cirrhosis and hepatic failure comparing Norfloxacin with Placebo (2 arms). Primary endpoint: 6-month mortality after admission. Started May 2009; status: active.
02
Drugs
norfloxacin
03
Conditions
Cirrhosishepatic failure
Beyond the preview
Go deeper on 2009-012919-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012919-17.